Recent Findings on Multivitamins and Aging
A study has revealed that taking a daily multivitamin for two years may slow some markers of biological aging. Conducted with 958 healthy participants, the research primarily involved older adults with an average age of about 70. This development raises questions about the role of multivitamins in promoting healthier aging.
Study Details and Results
Participants who took a daily multivitamin exhibited a slowdown in biological aging for two of five epigenetic clocks. The changes observed equated to roughly four months less biological aging over the two-year period. The multivitamin used in the study was Centrum Silver, and the research was part of a larger trial examining the effects of cocoa extract and multivitamins on health.
Context and Broader Implications
While these findings are intriguing, several large trials have previously failed to demonstrate meaningful mortality reduction from standard multivitamin supplementation in well-nourished populations. Biological age acceleration is associated with an elevated risk of various diseases, making the implications of this study particularly relevant. However, the study’s findings are not generalizable to other populations, as it only included older adults, mostly white, without major chronic illnesses.
Expert Opinions
Experts express caution regarding the general applicability of these findings. Dr. Dorsa Jalaei stated, “The honest answer, supported by the weight of current evidence, is, for most healthy adults eating a reasonably varied diet, no.” Howard Sesso added, “We are not yet in a position to recommend a daily multivitamin for all older adults,” highlighting the need for further research.
Small Changes and Future Research
Professor Fontana remarked on the study’s findings, saying, “The change was very, very small.” This suggests that while there may be some benefits, they are not substantial enough to warrant widespread recommendations. The science behind epigenetic clocks is still developing and not fully understood, indicating that more research is needed to clarify these results.
Funding and Support
The study was funded by Mars and the US National Institutes of Health, with Pfizer providing additional support. This backing underscores the importance of the research but also raises questions about potential biases in the findings.
Uncertainties and Future Directions
Details remain unconfirmed regarding the specific reasons why daily consumption of multivitamins may have impacted health markers. Furthermore, the long-term effects of multivitamins on healthspan and lifespan remain unconfirmed. They may not reduce disease risk or increase survival despite changes in epigenetic clocks. As research continues, experts hope to explore accessible, safe interventions that contribute to healthier, higher-quality aging.